Abstract
On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberculosis. In this review article, we address concurrent tuberculosis and COVID-19, with particular regard to the differences between Brazil and Europe. In addition, we discuss priorities in clinical care, public health, and research.
Author supplied keywords
Cite
CITATION STYLE
Silva, D. R., Mello, F. C. de Q., D’ambrosio, L., Centis, R., Dalcolmo, M. P., & Migliori, G. B. (2021). Tuberculosis and COVID-19, the new cursed duet: What differs between Brazil and Europe? Jornal Brasileiro de Pneumologia, 47(2). https://doi.org/10.36416/1806-3756/e20210044
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
